NU SKIN ENTERPRISES, INC. Restructuring Costs and Asset Impairment Charges
NU SKIN ENTERPRISES, INC. (NUS) reported Restructuring Costs and Asset Impairment Charges of $25.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-02-13
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for the quarter ending 2025-09-30 was $0.00.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for the quarter ending 2025-03-31 was $25.11M, a 252.03% increase year-over-year.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for fiscal 2025 was $25.11M, a 87.59% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for fiscal 2024 was $202.36M, a 922.54% increase from fiscal 2023.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for fiscal 2023 was $19.79M, a 59.19% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. restructuring costs and asset impairment charges for fiscal 2022 was $48.49M, a 6.51% decline from fiscal 2021.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $25.11M 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $25.11M 10-Q · filed 2025-11-07 | $70.99M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | $25.11M 10-Q · filed 2025-08-08 | $70.99M derived: sum of 3 quarters · filed 2026-02-13 | $70.99M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $25.11M 10-Q · filed 2025-05-09 | $70.99M derived: sum of 2 quarters · filed 2026-02-13 | $70.99M derived: sum of 3 quarters · filed 2026-02-13 | $220.34M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $45.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $45.88M derived: sum of 2 quarters · filed 2026-02-13 | $195.23M derived: sum of 3 quarters · filed 2026-02-13 | $202.36M 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $149.35M derived: sum of 2 quarters · filed 2025-11-07 | $156.48M 10-Q · filed 2025-11-07 | $166.49M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $149.35M 10-Q · filed 2025-08-08 | $156.48M 10-Q · filed 2025-08-08 | $166.49M derived: sum of 3 quarters · filed 2026-02-13 | $166.49M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $7.13M 10-Q · filed 2025-05-09 | $17.14M derived: sum of 2 quarters · filed 2026-02-13 | $17.14M derived: sum of 3 quarters · filed 2026-02-13 | $17.14M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $10.00M derived: sum of 2 quarters · filed 2026-02-13 | $10.00M derived: sum of 3 quarters · filed 2026-02-13 | $19.79M 10-K · filed 2026-02-13 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $9.79M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $9.79M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $9.79M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $48.49M 10-K · filed 2025-02-14 | |||
| 2021-12-31 | $51.87M 10-K · filed 2024-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |